Suppr超能文献

晚期恶性生殖细胞肿瘤男性患者的多模式治疗。II. 基于顺铂化疗后的手术和放疗经验。

Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cis-platinum-based chemotherapy.

作者信息

Fosså S D, Klepp O, Ous S, Lien H, Stenwig J T, Abeler V, Eliassen G, Høst H

出版信息

Scand J Urol Nephrol. 1984;18(1):21-6. doi: 10.3109/00365598409182159.

Abstract

After chemotherapy with cis-platinum, vinblastine and bleomycin, 33 surgical procedures were performed in 29 patients with advanced malignant germ-cell tumours. The tumour masses could be completely resected macroscopically in 26 patients. Histology of the operation specimens showed fibrosis/necrosis (9 specimens), mature teratome (13 specimens) and vital malignant tumour (11 specimens). Patients with fibrosis/necrosis or completely resected mature teratoma had an excellent prognosis, whereas only 5 of the 11 patients with vital malignant tumour survived in spite of second-line treatment with chemotherapy/radiotherapy. Preoperatively elevated serum levels of AFP, beta-HCG and/or LDH indicated the presence of residual vital malignant germ cell tumour. Eight of 14 patients were rendered tumour-free by radiotherapy given as second- or third-line treatment. In general, tumour masses, remaining after cis-platinum-based induction chemotherapy should be resected as completely as possible even in the case of mature teratoma or fibrosis/necrosis. Radiotherapy should be considered as second- and third-line treatment in selected patients.

摘要

对29例晚期恶性生殖细胞肿瘤患者采用顺铂、长春碱和博来霉素进行化疗后,实施了33次外科手术。26例患者的肿瘤块在肉眼下可完全切除。手术标本的组织学检查显示纤维化/坏死(9份标本)、成熟畸胎瘤(13份标本)和存活的恶性肿瘤(11份标本)。有纤维化/坏死或完全切除的成熟畸胎瘤的患者预后良好,而11例存活的恶性肿瘤患者中尽管接受了化疗/放疗的二线治疗,但只有5例存活。术前血清甲胎蛋白(AFP)、β-人绒毛膜促性腺激素(β-HCG)和/或乳酸脱氢酶(LDH)水平升高表明存在存活的恶性生殖细胞肿瘤残留。14例患者中有8例通过作为二线或三线治疗的放疗实现了无瘤状态。一般来说,即使是成熟畸胎瘤或纤维化/坏死的情况,基于顺铂的诱导化疗后残留的肿瘤块也应尽可能完全切除。对于选定的患者,应考虑将放疗作为二线和三线治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验